Keros Therapeutics, Inc. · NASDAQ:KROS
Newton Charles W. sold 551 Keros Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Newton Charles W. (Director) sold 551 Keros Therapeutics, Inc. shares at an average US$10.85 for US$5,981 under a trading plan, leaving 11,563 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 551 shares
- Price
- US$10.85 average (US$10.83 to US$11.05)
- Value
- US$5,981
- Holding after
- 11,563 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 491 | US$10.83 | 11,623 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 60 | US$11.05 | 11,563 | Direct |
Source
Download original · View original at SEC
Related
- Keros Therapeutics, Inc.
- Newton Charles W.
- Keros Therapeutics, Inc. shareholders
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Newton Charles W. · Jun 15, 2026
- Form 4 · Prener Anne · Nov 19, 2026
- Form 4 · Prener Anne · Nov 16, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Oct 27, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026